Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10400006
Estrogen receptor modulators
granted -
US 10399994
Compounds and methods for preventing or treating sensory hair cell death
granted -
US 10399962
Azolopyrimidine for the treatment of cancer-related disorders
granted -
US 10399943
Antifungal compound process
granted -
US 10398762
Methods and compositions for treating diabetes
granted -
US 10398778
Method for enhancing specific immunotherapies in cancer treatment
granted -
US 10399937
Ionizable cationic lipid for RNA delivery
granted -
US 10398776
Phonophoretic cannabidiol composition and transdermal delivery system
granted -
US 10399189
Airfoil aerodynamics
granted -
US 10398769
Influenza nucleic acid molecules and vaccines made therefrom
granted -
US 10400253
Methods and compositions or RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10400239
Compositions and methods for inhibiting expression of the ALAS1 gene
granted -
US 10400238
Polynucleotide agents targeting complement component C5 and methods of use thereof
granted -
US 10400045
Internalizing human monoclonal antibodies targeting prostate and other cancer cells
granted -
US 10400031
Identification of antibodies specific for lyssaviruses and methods of their use
granted -
US 10400025
VEGF antagonist formulations suitable for intravitreal administration
granted -
US 10400029
Serpin fusion polypeptides and methods of use thereof
granted -
US 10400225
TAL effector-mediated DNA modification
granted -
US 10400036
Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A
granted -
US 10399993
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
granted -
US 10391183
Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
granted -
US 10392642
High molecular weight heparosan polymers and methods of production and use thereof
granted -
US 10392618
Micro-RNA family that modulates extracellular matrix genes and uses thereof
granted -
US 10392441
IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.